Clinical efficacy of alprostadil combined with α-lipoic acid in the treatment of elderly patients with diabetic nephropathy
Y Hong, J Peng, X Cai, X Zhang, Y Liao, L Lan - Open Medicine, 2017 - degruyter.com
Objective To evaluate the effect and toxicity of alprostadil combined with thioctic acid
injection in the treatment of patients with diabetic nephropathy (DN). Methods Sixty two …
injection in the treatment of patients with diabetic nephropathy (DN). Methods Sixty two …
[HTML][HTML] The effects of alprostadil combined with α-lipoic acid in the treatment of senile diabetic nephropathy
X Cao, P Chen - American Journal of Translational Research, 2021 - ncbi.nlm.nih.gov
Objective: This study aimed to investigate the clinical efficacy of alprostadil combined with α-
Lipoic acid (α-LA) in the treatment of senile diabetic nephropathy (SDN) and the …
Lipoic acid (α-LA) in the treatment of senile diabetic nephropathy (SDN) and the …
[PDF][PDF] Curative effects of valsartan alone or combined with alpha-lipoic acid on inflammatory cytokines and renal function in early-stage diabetic kidney disease
Z Jiang, Z Tan, F Meng, X Li - J Coll Physicians Surg Pak, 2019 - jcpsp.pk
The aim of this study was to compare curative effects of valsartan alone or combined with
alpha-lipoic acid (ALA) on inflammatory cytokine indices including hypersensitive C-reactive …
alpha-lipoic acid (ALA) on inflammatory cytokine indices including hypersensitive C-reactive …
[HTML][HTML] Combined treatment of diabetic nephropathy with alprostadil and calcium dobesilate
L Qin, W Qin, J Wang, L Lin - Experimental and …, 2017 - spandidos-publications.com
This study investigated the effects of alprostadil combined with calcium dobesilate on the
treatment of diabetic nephropathy. We recruited 80 patients with diabetic nephropathy, who …
treatment of diabetic nephropathy. We recruited 80 patients with diabetic nephropathy, who …
Prospective analysis of the efficacy of beraprost sodium combined with alprostadil on diabetic nephropathy and influence on rennin-angiotensin system and TNF-α
X Xu, X Pan, S Li - Experimental and Therapeutic …, 2020 - spandidos-publications.com
Efficacy of beraprost sodium (BPS) combined with alprostadil on diabetic nephropathy (DN)
and its influence on renin angiotensin system (RAS) and TNF-α were investigated. One …
and its influence on renin angiotensin system (RAS) and TNF-α were investigated. One …
Effects of alpha lipoic acid supplementation on serum levels of IL-8 and TNF-α in patient with ESRD undergoing hemodialysis
J Safa, MR Ardalan, M Rezazadehsaatlou… - … urology and nephrology, 2014 - Springer
Background Chronic renal failure is a progressive and irreversible loss of kidney function,
and the hemodialysis (HD) is one of the most common modalities in this regard. Oxidative …
and the hemodialysis (HD) is one of the most common modalities in this regard. Oxidative …
[HTML][HTML] Efficacy of epalrestat combined with alprostadil for diabetic nephropathy and its impacts on renal fibrosis and related factors of inflammation and oxidative …
Y Zhou, R Wang, F Han, J Zhang - American Journal of …, 2022 - ncbi.nlm.nih.gov
Objective: To explore the efficacy of epalrestat (Ep) combined with alprostadil (Alp) in the
treatment of diabetic nephropathy (DN) and its impacts on renal fibrosis (RF) and …
treatment of diabetic nephropathy (DN) and its impacts on renal fibrosis (RF) and …
Effects of different doses of irbesartan combined with spironolactone on urinary albumin excretion rate in elderly patients with early type 2 diabetic nephropathy
Y Chen, P Liu, X Chen, Y Li, F Zhang… - The American Journal of …, 2018 - Elsevier
Background There is a lack of research on the effect of low dose of angiotensin receptor
blockers combined with spironolactone, and the effect of high dose of angiotensin receptor …
blockers combined with spironolactone, and the effect of high dose of angiotensin receptor …
Effects of valsartan combined with α-lipoic acid on renal function in patients with diabetic nephropathy: a systematic review and meta-analysis
F Sun, D Jiang, J Cai - BMC endocrine disorders, 2021 - Springer
Background Diabetic nephropathy (DN) is one of the most serious microvascular
complications of diabetes, valsartan and α-lipoic acid alone or in combination has been …
complications of diabetes, valsartan and α-lipoic acid alone or in combination has been …
[HTML][HTML] Efficacy of pentoxifylline for reduction of proteinuria in type II diabetic patients
F Oliaei, S Hushmand, S Khafri… - Caspian journal of …, 2011 - ncbi.nlm.nih.gov
Background: Diabetic nephropathy is considered to be the most common cause of end stage
renal disease (ESRD). Proteinuria is declared as the most marked risk factor in progression …
renal disease (ESRD). Proteinuria is declared as the most marked risk factor in progression …
相关搜索
- elderly patients diabetic nephropathy
- acid in the treatment diabetic nephropathy
- acid in the treatment elderly patients
- acid in the treatment clinical efficacy
- clinical efficacy diabetic nephropathy
- clinical efficacy elderly patients
- efficacy of pentoxifylline diabetic patients
- renal function diabetic nephropathy
- tnf α diabetic nephropathy
- effects of valsartan diabetic nephropathy
- glycemic control diabetic patients
- combined treatment calcium dobesilate
- rennin angiotensin diabetic nephropathy
- beraprost sodium diabetic nephropathy
- calcium dobesilate diabetic nephropathy
- early type diabetic nephropathy